ELISA microarray technology as a high-throughput system for cancer biomarker validation.
about
Lab-on-a-Chip Magneto-Immunoassays: How to Ensure Contact between Superparamagnetic Beads and the Sensor SurfaceMass spectrometry-based approaches to targeted quantitative proteomics in cardiovascular diseasePhthalic acid chemical probes synthesized for protein-protein interaction analysisA multiplexed device based on tunable nanoshearing for specific detection of multiple protein biomarkers in serum.The PAXgene(®) tissue system preserves phosphoproteins in human tissue specimens and enables comprehensive protein biomarker researchELISA-BASE: an integrated bioinformatics tool for analyzing and tracking ELISA microarray data.Spatially selective photonic crystal enhanced fluorescence and application to background reduction for biomolecule detection assays.Network analysis of epidermal growth factor signaling using integrated genomic, proteomic and phosphorylation dataTiny grains give huge gains: nanocrystal-based signal amplification for biomolecule detection.Sensitive detection of protein and miRNA cancer biomarkers using silicon-based photonic crystals and a resonance coupling laser scanning platformColorimetric immunoassay for detection of tumor markers.A proteomics platform combining depletion, multi-lectin affinity chromatography (M-LAC), and isoelectric focusing to study the breast cancer proteomeA proteomic approach to obesity and type 2 diabetes.Evaluation of surface chemistries for antibody microarrays.Serum apolipoprotein A-1 quantification by LC-MS with a SILAC internal standard reveals reduced levels in smokers.Simultaneous and sensitive detection of six serotypes of botulinum neurotoxin using enzyme-linked immunosorbent assay-based protein antibody microarrays.Biomarker discovery in mass spectrometry-based urinary proteomics.Macrophage responses to silica nanoparticles are highly conserved across particle sizes.Proteomics-based diagnosis of chronic obstructive pulmonary disease: the hunt for new markers.Microarray methods for protein biomarker detectionUnleashing the power of proteomics to develop blood-based cancer markers.Electrical biosensors and the label free detection of protein disease biomarkers.Multiplatform Biomarker Discovery for Bladder Cancer Recurrence Diagnosis.SERS-based immunoassay of tumor marker VEGF using DNA aptamers and silica-encapsulated hollow gold nanospheres.5D proteomic approach for the biomarker search in plasma: Acute myeloid leukaemia as a case study.Neuroproteomics Studies: Challenges and Updates.A comparative Study of Aptasensor Vs Immunosensor for Label-Free PSA Cancer Detection on GQDs-AuNRs Modified Screen-Printed Electrodes.Electrohydrodynamic-Induced SERS Immunoassay for Extensive Multiplexed Biomarker Sensing.Versatile immunoassays based on isomagnetophoresis.
P2860
Q27016020-9A7408D6-3117-41F1-9138-FCB3FFA51903Q28075372-503FC34B-8F11-427B-8773-D1F8406B48EDQ28387205-F1B26C0F-7706-4D4F-982E-7A1F50E38940Q30650658-5771CD0E-3F2C-4600-BEAF-AF8ABDB9534CQ31114691-15E0A42F-D766-48A2-AF59-826D9CCAC21AQ33426753-6B4C80CC-E4C9-4C9E-980E-161F401DFA19Q34080821-12CE4C2D-4175-442F-B331-39707FDD6C5FQ34222630-265E1A89-6467-4267-B9F7-8C999DCEBE1DQ34713768-55DEDD08-B688-4E13-B8B5-4F11C32AA56AQ34959748-C6179BF7-D98A-4819-8825-51E5036E0C18Q35002196-FF7DC7AA-8501-4051-AB40-54BB626A8A32Q35140579-17C56905-0C87-40D3-A85C-1F966B3A9093Q35879468-47E49CBC-1483-466E-BE71-A82C758A6B2BQ36122874-D2CDF73F-5643-44C7-887C-8307C1190E19Q36533665-F102DE40-32D1-49E0-A5AE-1976991A1E04Q36661573-26E24015-3300-4764-9D35-2D4C1E6F685EQ36956324-6120AA4A-1688-4FC6-AAE7-A05E4392E016Q37091537-BA471CFB-848C-4DE6-BF81-6312DA800A2EQ37304126-FEFC70C5-220B-43EA-ADC0-F9E1276F47F0Q37335033-E2273BEB-4821-4EC2-8CBC-20B361A4BE07Q38055674-8BA567C4-B76D-439A-8F73-ED980AB7C796Q38101491-C8ABF11C-E785-4C79-84DC-FAF2ECD40351Q39359483-DC7F631A-99B6-475F-ABFA-6900696E15CCQ44469087-93EEF459-853B-448B-82B3-3BD35F3950E8Q47101230-5C735CCD-0685-46DC-AA72-F55F0F2C2A60Q47721773-2E5765CE-9A71-4BD4-91B2-8D5624760B06Q49195600-78E39F6F-4C79-4472-88DC-536E10675AADQ51242934-8DFB2007-B31C-451D-8922-CF1FEF2E54B6Q51548952-8D1E0D26-3126-4545-AABD-4BF9033C04FF
P2860
ELISA microarray technology as a high-throughput system for cancer biomarker validation.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
ELISA microarray technology as a high-throughput system for cancer biomarker validation.
@ast
ELISA microarray technology as a high-throughput system for cancer biomarker validation.
@en
type
label
ELISA microarray technology as a high-throughput system for cancer biomarker validation.
@ast
ELISA microarray technology as a high-throughput system for cancer biomarker validation.
@en
prefLabel
ELISA microarray technology as a high-throughput system for cancer biomarker validation.
@ast
ELISA microarray technology as a high-throughput system for cancer biomarker validation.
@en
P2093
P2860
P356
P1476
ELISA microarray technology as a high-throughput system for cancer biomarker validation.
@en
P2093
Amanda M White
Don S Daly
Richard C Zangar
P2860
P356
10.1586/14789450.3.1.37
P577
2006-02-01T00:00:00Z